Cisplatin

CREB regulated transcription coactivator 2 ; Mus musculus







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35238644 Activation of Rictor/mTORC2 signaling acts as a pivotal strategy to protect against sensorineural hearing loss. 2022 Mar 8 1
2 34126157 Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway. 2021 Aug 1
3 31744897 Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment. 2020 Feb 2
4 32508971 EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin. 2020 1
5 32528729 Loss of Rictor in tubular cells exaggerates lipopolysaccharide induced renal inflammation and acute kidney injury via Yap/Taz-NF-κB axis. 2020 1
6 33144587 Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies. 2020 Nov 3 1
7 24451322 Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury. 2014 Jul 2
8 24840134 Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis. 2014 Jul 1
9 23528835 Sustained overexpression of Redd1 leads to Akt activation involved in cell survival. 2013 Aug 19 1
10 23838676 A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin. 2013 Oct 1
11 24086535 The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells. 2013 1
12 22586651 mTORC 2:1 for chemotherapy sensitization in glioblastoma. 2011 Nov 1